中国卒中杂志
中國卒中雜誌
중국졸중잡지
CHINESE JOURNAL OF STROKE
2013年
9期
768-772
,共5页
刘勇%冯国栋%张光运%韩军良%赵钢
劉勇%馮國棟%張光運%韓軍良%趙鋼
류용%풍국동%장광운%한군량%조강
卒中%神经保护策略%人参皂苷Rd
卒中%神經保護策略%人參皂苷Rd
졸중%신경보호책략%인삼조감Rd
Stroke%Neuroprotective strategy%Ginsenoside Rd
目前正在进行的卒中神经保护策略研究主要有白蛋白、镁和低温治疗等;一些有前景的神经保护剂如人参皂苷Rd(ginsenoside Rd,GSRd)、突触后膜密95蛋白阻断剂NA-1(a 20-amino acid peptide,Tat-NR2B9c)等的研究还在探索中。神经保护研究的30年经历了由高潮到低谷再到新高潮的发展阶段,而未来神经保护治疗的研究要取得更好的发展需注重:动物实验中的严格设计,研究对象应从龋齿动物向灵长类动物转化,评价方法由行为评估向影像学评估转变;而整体研究范式应扩展到血管神经网络。
目前正在進行的卒中神經保護策略研究主要有白蛋白、鎂和低溫治療等;一些有前景的神經保護劑如人參皂苷Rd(ginsenoside Rd,GSRd)、突觸後膜密95蛋白阻斷劑NA-1(a 20-amino acid peptide,Tat-NR2B9c)等的研究還在探索中。神經保護研究的30年經歷瞭由高潮到低穀再到新高潮的髮展階段,而未來神經保護治療的研究要取得更好的髮展需註重:動物實驗中的嚴格設計,研究對象應從齲齒動物嚮靈長類動物轉化,評價方法由行為評估嚮影像學評估轉變;而整體研究範式應擴展到血管神經網絡。
목전정재진행적졸중신경보호책략연구주요유백단백、미화저온치료등;일사유전경적신경보호제여인삼조감Rd(ginsenoside Rd,GSRd)、돌촉후막밀95단백조단제NA-1(a 20-amino acid peptide,Tat-NR2B9c)등적연구환재탐색중。신경보호연구적30년경력료유고조도저곡재도신고조적발전계단,이미래신경보호치료적연구요취득경호적발전수주중:동물실험중적엄격설계,연구대상응종우치동물향령장류동물전화,평개방법유행위평고향영상학평고전변;이정체연구범식응확전도혈관신경망락。
Many ongoing studies of neuroprotective strategy of stroke include albumin, magnesium and cryotherapy therapy. There are also a number of promising neuroprotectants in preclinical development including ginsenoside Rd, NA-1 (Tat-NR2B9c), an inhibitor of postsynaptic density-95 protein etc. Thirty years' study of neuroprotective strategy of stroke experiences the development process from the peak to the trough then to new climax. However, to achieve better development, future research should focus on:conduct a strict design;the object of study should converse from dental caries animal to primate;the evaluation method should converse from behavioral assessment to radiographic evaluation;research paradigm should extend to vascular neural network.